Health
Drug Breakthrough for Pancreatic Cancer
Daraxonrasib, a new drug, has been shown to double survival time for pancreatic cancer patients. This breakthrough is seen as a significant advancement in the treatment of one of the deadliest cancers.
Coverage timeline — 1 article
BBC News
The drug, daraxonrasib, has been hailed as a breakthrough in managing the deadliest of all the major cancers.
2026-06-01 02:50 UTC